Equities

Key statistics

On Friday, Bristol-Myers Squibb Co (BRM:BRN) closed at 46.20, 0.13% above its 52-week low of 46.14, set on Jan 04, 2019.
52-week range
Today
46.14Jan 04 201946.65Jan 04 2019
Markit short selling activity
Low
Med
High
Open46.65
High46.65
Low46.14
Bid46.20
Offer46.33
Previous close46.20
Average volume--
Shares outstanding1.64bn
Free float1.63bn
P/E (TTM)15.06
Market cap77.80bn USD
EPS (TTM)3.16
USD
Annual div (ADY)1.63
CHF
Annual div yield (ADY)--
Div ex-dateApr 04 2019
Div pay-dateMay 01 2019
Next div ex-dateJul 03 2019
Next div pay-dateAug 01 2019
Data delayed at least 15 minutes, as of Jan 04 2019.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.